PATENT CLAIM ANALYSIS

Application Number: 16093160
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "267000"]

Abstract:
The present disclosure provides compounds represented by Formula I: and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein B, R 1 , R 5 , Q 1 , Q″, L, X, Y, and Z are as defined as set forth in the specification. The present disclosure also provids compounds of Formula I for use to treat a condition or disorder responsive to degradation of BET bromodomains such as cancer.

Claim (Index 57):
The compound of  claim 56  for use in treating cancer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.47273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14204076', '15619671', '14633360', '15443336', '15553593']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8238206371513698
- 35 USC 102 Novelty (BERT): 0.5434097426673434
- Combined Prediction Score: 0.7957795477029671
- Mean Citation Score: 383.15725
- Max Citation Score: 427.83923
- Similarity Product: 231.403955404656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test